Net Cash Provided by (Used in) Operating Activities |
71M |
USD |
-61% |
Q1 2025 |
Q1 2025 |
Net Cash Provided by (Used in) Financing Activities |
-780M |
USD |
+66.9% |
Q1 2025 |
Q1 2025 |
Net Cash Provided by (Used in) Investing Activities |
661M |
USD |
-71.6% |
Q1 2025 |
Q1 2025 |
Common Stock, Shares Authorized |
1.13B |
shares |
0% |
Q1 2025 |
Q1 2025 |
Common Stock, Shares, Issued |
467M |
shares |
+0.43% |
Q1 2025 |
Q1 2025 |
Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q1 2025 |
Q1 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-48M |
USD |
-131% |
Q1 2025 |
Q1 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
2.06B |
USD |
-30.3% |
Q1 2025 |
Q1 2025 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
703M |
USD |
-18.8% |
Q1 2025 |
Q1 2025 |
Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
43M |
USD |
-69.1% |
Q1 2025 |
Q1 2025 |
Deferred Tax Assets, Operating Loss Carryforwards |
9M |
USD |
-18.2% |
Q4 2024 |
FY 2024 |
Unrecognized Tax Benefits |
47.1M |
USD |
-2.89% |
Q4 2024 |
FY 2024 |
Amortization of Intangible Assets |
2M |
USD |
-33.3% |
Q3 2024 |
Q3 2024 |
Deferred Tax Assets, Net of Valuation Allowance |
302M |
USD |
-11.7% |
Q4 2024 |
FY 2024 |
Interest Expense |
3.52B |
USD |
+10% |
Q2 2024 |
Q2 2024 |